pyrvinium has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afzal, O; Al-Abbasi, FA; Alfawaz Altamimi, AS; Alharbi, KS; Alzarea, SI; Chellappan, DK; Dua, K; Gupta, G; Kazmi, I; Singh, SK; Singh, Y | 1 |
| Cespedes, C; Cuevas, CA; Inestrosa, NC; Tapia-Rojas, C; Vio, CP | 1 |
1 review(s) available for pyrvinium and Blood Pressure, High
| Article | Year |
|---|---|
Molecular explanation of Wnt/βcatenin antagonist pyrvinium mediated calcium equilibrium changes in aging cardiovascular disorders.
Topics: Aging; Animals; beta Catenin; Calcium; Cardiovascular Diseases; Hypertension; Myocardium; Rats; Wnt Signaling Pathway | 2022 |
1 other study(ies) available for pyrvinium and Blood Pressure, High
| Article | Year |
|---|---|
β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.
Topics: Angiotensin II; Animals; beta Catenin; Blood Pressure; Cyclin D1; Fibrosis; Humans; Hypertension; Kidney; Kidney Diseases; Lisinopril; Proto-Oncogene Proteins c-myc; Pyrvinium Compounds; Rats; Signal Transduction | 2015 |